vs
Side-by-side financial comparison of PATHWARD FINANCIAL, INC. (CASH) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $173.1M, roughly 1.7× PATHWARD FINANCIAL, INC.). PATHWARD FINANCIAL, INC. runs the higher net margin — 20.3% vs 12.8%, a 7.5% gap on every dollar of revenue. On growth, PATHWARD FINANCIAL, INC. posted the faster year-over-year revenue change (-0.2% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -18.0%).
Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
CASH vs TECH — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $173.1M | $295.9M |
| Net Profit | $35.2M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 24.6% | 18.4% |
| Net Margin | 20.3% | 12.8% |
| Revenue YoY | -0.2% | -6.4% |
| Net Profit YoY | 11.9% | 68.3% |
| EPS (diluted) | $1.57 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $173.1M | $295.9M | ||
| Q3 25 | $186.7M | — | ||
| Q2 25 | $195.8M | $317.0M | ||
| Q1 25 | $274.8M | $316.2M | ||
| Q4 24 | $182.6M | $297.0M | ||
| Q3 24 | $179.5M | $289.5M | ||
| Q2 24 | $188.6M | $306.1M | ||
| Q1 24 | $257.6M | $303.4M |
| Q4 25 | $35.2M | $38.0M | ||
| Q3 25 | $38.8M | — | ||
| Q2 25 | $42.1M | $-17.7M | ||
| Q1 25 | $75.0M | $22.6M | ||
| Q4 24 | $30.0M | $34.9M | ||
| Q3 24 | $33.5M | $33.6M | ||
| Q2 24 | $44.9M | $40.6M | ||
| Q1 24 | $69.9M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | 24.6% | 18.4% | ||
| Q3 25 | 25.9% | — | ||
| Q2 25 | 24.1% | -7.5% | ||
| Q1 25 | 33.2% | 12.2% | ||
| Q4 24 | 19.8% | 16.0% | ||
| Q3 24 | 20.9% | 13.8% | ||
| Q2 24 | 27.1% | 15.0% | ||
| Q1 24 | 33.8% | 22.1% |
| Q4 25 | 20.3% | 12.8% | ||
| Q3 25 | 20.8% | — | ||
| Q2 25 | 21.5% | -5.6% | ||
| Q1 25 | 27.3% | 7.1% | ||
| Q4 24 | 16.4% | 11.7% | ||
| Q3 24 | 18.7% | 11.6% | ||
| Q2 24 | 23.8% | 13.3% | ||
| Q1 24 | 27.1% | 16.2% |
| Q4 25 | $1.57 | $0.24 | ||
| Q3 25 | $1.69 | — | ||
| Q2 25 | $1.81 | $-0.11 | ||
| Q1 25 | $3.14 | $0.14 | ||
| Q4 24 | $1.23 | $0.22 | ||
| Q3 24 | $1.34 | $0.21 | ||
| Q2 24 | $1.78 | $0.26 | ||
| Q1 24 | $2.74 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $331.2M | $172.9M |
| Total DebtLower is stronger | $33.5M | $260.0M |
| Stockholders' EquityBook value | $854.5M | $2.0B |
| Total Assets | $7.6B | $2.5B |
| Debt / EquityLower = less leverage | 0.04× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $331.2M | $172.9M | ||
| Q3 25 | $120.6M | — | ||
| Q2 25 | $258.3M | $162.2M | ||
| Q1 25 | $254.2M | $140.7M | ||
| Q4 24 | $597.4M | $177.5M | ||
| Q3 24 | $158.3M | $187.5M | ||
| Q2 24 | $298.9M | $152.9M | ||
| Q1 24 | $347.9M | $145.3M |
| Q4 25 | $33.5M | $260.0M | ||
| Q3 25 | $33.5M | — | ||
| Q2 25 | $33.4M | $346.0M | ||
| Q1 25 | $33.4M | $330.0M | ||
| Q4 24 | $33.4M | $300.0M | ||
| Q3 24 | $33.4M | $300.0M | ||
| Q2 24 | $33.3M | $319.0M | ||
| Q1 24 | $33.4M | $389.0M |
| Q4 25 | $854.5M | $2.0B | ||
| Q3 25 | $858.0M | — | ||
| Q2 25 | $819.0M | $1.9B | ||
| Q1 25 | $814.7M | $2.0B | ||
| Q4 24 | $758.3M | $2.1B | ||
| Q3 24 | $822.5M | $2.1B | ||
| Q2 24 | $748.4M | $2.1B | ||
| Q1 24 | $719.5M | $2.0B |
| Q4 25 | $7.6B | $2.5B | ||
| Q3 25 | $7.2B | — | ||
| Q2 25 | $7.2B | $2.6B | ||
| Q1 25 | $7.0B | $2.6B | ||
| Q4 24 | $7.6B | $2.7B | ||
| Q3 24 | $7.5B | $2.7B | ||
| Q2 24 | $7.5B | $2.7B | ||
| Q1 24 | $7.4B | $2.7B |
| Q4 25 | 0.04× | 0.13× | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.04× | 0.18× | ||
| Q1 25 | 0.04× | 0.16× | ||
| Q4 24 | 0.04× | 0.14× | ||
| Q3 24 | 0.04× | 0.14× | ||
| Q2 24 | 0.04× | 0.15× | ||
| Q1 24 | 0.05× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $108.3M | — |
| Free Cash FlowOCF − Capex | $104.1M | — |
| FCF MarginFCF / Revenue | 60.1% | — |
| Capex IntensityCapex / Revenue | 2.4% | — |
| Cash ConversionOCF / Net Profit | 3.08× | — |
| TTM Free Cash FlowTrailing 4 quarters | $616.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.3M | — | ||
| Q3 25 | $303.7M | — | ||
| Q2 25 | $30.4M | $98.2M | ||
| Q1 25 | $188.3M | $41.1M | ||
| Q4 24 | $-71.7M | $84.3M | ||
| Q3 24 | $143.1M | $63.9M | ||
| Q2 24 | $113.2M | $75.5M | ||
| Q1 24 | $203.0M | $81.0M |
| Q4 25 | $104.1M | — | ||
| Q3 25 | $300.3M | — | ||
| Q2 25 | $27.7M | $93.3M | ||
| Q1 25 | $184.7M | $31.0M | ||
| Q4 24 | $-73.8M | $77.5M | ||
| Q3 24 | $138.8M | $54.7M | ||
| Q2 24 | $111.0M | $57.5M | ||
| Q1 24 | $201.3M | $64.5M |
| Q4 25 | 60.1% | — | ||
| Q3 25 | 160.9% | — | ||
| Q2 25 | 14.1% | 29.4% | ||
| Q1 25 | 67.2% | 9.8% | ||
| Q4 24 | -40.4% | 26.1% | ||
| Q3 24 | 77.3% | 18.9% | ||
| Q2 24 | 58.8% | 18.8% | ||
| Q1 24 | 78.1% | 21.3% |
| Q4 25 | 2.4% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 1.4% | 1.5% | ||
| Q1 25 | 1.3% | 3.2% | ||
| Q4 24 | 1.1% | 2.3% | ||
| Q3 24 | 2.4% | 3.2% | ||
| Q2 24 | 1.2% | 5.9% | ||
| Q1 24 | 0.7% | 5.4% |
| Q4 25 | 3.08× | — | ||
| Q3 25 | 7.83× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 2.51× | 1.82× | ||
| Q4 24 | -2.39× | 2.42× | ||
| Q3 24 | 4.27× | 1.90× | ||
| Q2 24 | 2.52× | 1.86× | ||
| Q1 24 | 2.90× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CASH
| Consumer | $103.0M | 59% |
| Payment Card And Deposit Fees | $30.1M | 17% |
| Other | $24.2M | 14% |
| Rental Income | $11.6M | 7% |
| Commercial | $4.2M | 2% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
